VIRX (Viracta Therapeutics) Float Percentage Of Total Shares Outstanding: 78.83% (As of Jul. 03, 2026)


What is Viracta Therapeutics Float Percentage Of Total Shares Outstanding?

Viracta Therapeutics VIRX Float Percentage Of Total Shares Outstanding is 78.83% as of Jul. 03, 2026.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Viracta Therapeutics's float shares is 31.33 Mil. Viracta Therapeutics's total shares outstanding is 39.74 Mil. Viracta Therapeutics's float percentage of total shares outstanding is 78.83%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Viracta Therapeutics's Insider Ownership is 3.06%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Viracta Therapeutics's Institutional Ownership is 0.39%.

Viracta Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Viracta Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=31.33/39.74
=78.83%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 78.83% mean?
Viracta Therapeutics (VIRX) has a Float Percentage Of Total Shares Outstanding of 78.83% as of Jul. 03, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Viracta Therapeutics and its competitors.
Is Viracta Therapeutics' Float Percentage Of Total Shares Outstanding too high?
Viracta Therapeutics' current Float Percentage Of Total Shares Outstanding is 78.83%.
How does Viracta Therapeutics' Float Percentage Of Total Shares Outstanding compare to TSOI and CYTOF?
Viracta Therapeutics' Float Percentage Of Total Shares Outstanding of 78.83% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Viracta Therapeutics and its competitors. Viracta Therapeutics's current Float Percentage Of Total Shares Outstanding is 78.83%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viracta Therapeutics stock overvalued right now?
Viracta Therapeutics (VIRX) has a current Float Percentage Of Total Shares Outstanding of 78.83%. The current Float Percentage Of Total Shares Outstanding is 78.83%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Viracta Therapeutics (VIRX), the current Float Percentage Of Total Shares Outstanding is 78.83% as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Viracta Therapeutics Business Description

Address 2533 South Coast Highway 101, Suite 210, Cardiff, CA, USA, 92007
Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. The product candidate of the company is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people with organ transplants.